Race, social vulnerability, and specialist access linked to late-stage gynecologic cancer diagnosis

A population-based cross-sectional study of nearly 1.4 million US patients diagnosed with endometrial, ovarian, cervical, or uterine sarcoma cancers from 2001 to 2019 examined how race/ethnicity, county-level Social Vulnerability Index, and geographic access to gynecologic oncologists relate to stage at diagnosis. The study reported that non-Hispanic Black, Hispanic, and Asian/Pacific Islander women had significantly higher adjusted odds of late-stage diagnosis than non-Hispanic White women, and that residence in high social vulnerability counties or in counties with no gynecologic oncologist within 100 miles was also associated with higher odds of late-stage diagnosis. The authors also noted interactions between race/ethnicity and social vulnerability for endometrial and cervical cancers, and reported that late-stage cervical cancer diagnoses declined over the study period while late-stage endometrial cancer and uterine sarcoma diagnoses increased.

Most relevant for: Clinicians and health systems involved in diagnosing and managing endometrial, ovarian, cervical, or uterine sarcoma cancers, particularly in racially/ethnically diverse or socially vulnerable populations with limited geographic access to gynecologic oncology specialists.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.